LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 89 of 166
Next
>>
>
2201 to 2225 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	PD173074	3.33	uM	LJP6	72	hr	1334	4437	3925	1.1302	1.1624
BT-20	PD173074	10	uM	LJP6	72	hr	1334	2948	3925	0.7512	0.6640
BT-20	Crizotinib	0.04	uM	LJP5	72	hr	1334	3325	4033	0.8245	0.7716
BT-20	Crizotinib	0.12	uM	LJP5	72	hr	1334	3808	4033	0.9443	0.9295
BT-20	Crizotinib	0.37	uM	LJP5	72	hr	1334	3429	4033	0.8502	0.8064
BT-20	Crizotinib	1.11	uM	LJP5	72	hr	1334	3151	4033	0.7812	0.7127
BT-20	Crizotinib	3.33	uM	LJP5	72	hr	1334	2309	4033	0.5722	0.4089
BT-20	Crizotinib	10	uM	LJP5	72	hr	1334	1070	4033	0.2653	-0.1298
BT-20	BMS345541	0.04	uM	LJP6	72	hr	1334	4026	3925	1.0253	1.0310
BT-20	BMS345541	0.12	uM	LJP6	72	hr	1334	3799	3925	0.9679	0.9580
BT-20	BMS345541	0.37	uM	LJP6	72	hr	1334	3830	3925	0.9755	0.9671
BT-20	BMS345541	1.11	uM	LJP6	72	hr	1334	3750	3925	0.9553	0.9416
BT-20	BMS345541	3.33	uM	LJP6	72	hr	1334	3479	3925	0.8862	0.8489
BT-20	BMS345541	10	uM	LJP6	72	hr	1334	1747	3925	0.4452	0.1858
BT-20	KIN001-043	0.04	uM	LJP6	72	hr	1334	3878	3925	0.9882	0.9848
BT-20	KIN001-043	0.12	uM	LJP6	72	hr	1334	3691	3925	0.9407	0.9223
BT-20	KIN001-043	0.37	uM	LJP6	72	hr	1334	3439	3925	0.8764	0.8362
BT-20	KIN001-043	1.11	uM	LJP6	72	hr	1334	3446	3925	0.8782	0.8392
BT-20	KIN001-043	3.33	uM	LJP6	72	hr	1334	3836	3925	0.9775	0.9710
BT-20	KIN001-043	10	uM	LJP6	72	hr	1334	3001	3925	0.7646	0.6826
BT-20	Saracatinib	0.04	uM	LJP6	72	hr	1334	3861	3925	0.9836	0.9786
BT-20	Saracatinib	0.12	uM	LJP6	72	hr	1334	3738	3925	0.9522	0.9370
BT-20	Saracatinib	0.37	uM	LJP6	72	hr	1334	3628	3925	0.9240	0.9002
BT-20	Saracatinib	1.11	uM	LJP6	72	hr	1334	3485	3925	0.8881	0.8530
BT-20	Saracatinib	3.33	uM	LJP6	72	hr	1334	3169	3925	0.8075	0.7421

|<
<<
Previous
Page 89 of 166
Next
>>
>
2201 to 2225 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)